Analyzing Astrana Health (NASDAQ:ASTH) & Greenpro Capital (NASDAQ:GRNQ)

Astrana Health (NASDAQ:ASTHGet Free Report) and Greenpro Capital (NASDAQ:GRNQGet Free Report) are both medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their analyst recommendations, institutional ownership, dividends, profitability, valuation, risk and earnings.

Risk & Volatility

Astrana Health has a beta of 1.24, suggesting that its share price is 24% more volatile than the S&P 500. Comparatively, Greenpro Capital has a beta of 1.53, suggesting that its share price is 53% more volatile than the S&P 500.

Earnings & Valuation

This table compares Astrana Health and Greenpro Capital”s gross revenue, earnings per share and valuation.

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Astrana Health $1.72 billion 1.38 $60.72 million $1.30 32.39
Greenpro Capital $3.48 million 2.32 $1.07 million ($0.86) -1.24

Astrana Health has higher revenue and earnings than Greenpro Capital. Greenpro Capital is trading at a lower price-to-earnings ratio than Astrana Health, indicating that it is currently the more affordable of the two stocks.

Insider & Institutional Ownership

52.8% of Astrana Health shares are held by institutional investors. Comparatively, 0.9% of Greenpro Capital shares are held by institutional investors. 8.5% of Astrana Health shares are held by insiders. Comparatively, 45.4% of Greenpro Capital shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

Profitability

This table compares Astrana Health and Greenpro Capital’s net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Astrana Health 3.63% 9.37% 5.32%
Greenpro Capital -244.59% -119.86% -88.60%

Analyst Recommendations

This is a summary of current recommendations and price targets for Astrana Health and Greenpro Capital, as provided by MarketBeat.com.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Astrana Health 0 1 6 1 3.00
Greenpro Capital 0 0 0 0 0.00

Astrana Health currently has a consensus price target of $65.17, suggesting a potential upside of 54.75%. Given Astrana Health’s stronger consensus rating and higher probable upside, equities analysts clearly believe Astrana Health is more favorable than Greenpro Capital.

Summary

Astrana Health beats Greenpro Capital on 12 of the 15 factors compared between the two stocks.

About Astrana Health

(Get Free Report)

Astrana Health, Inc., Inc., a physician-centric technology-powered healthcare management company, provides medical care services in the United States. It operates through three segments: Care Partners, Care Delivery, and Care Enablement. The company is leveraging its proprietary population health management and healthcare delivery platform, operates an integrated, value-based healthcare model which empowers the providers in its network to deliver care to its patients. It offers care coordination services to patients, families, primary care physicians, specialists, acute care hospitals, alternative sites of inpatient care, physician groups, and health plans. The company's physician network consists of primary care physicians, specialist physicians and extenders, and hospitalists. It serves patients, primarily covered by private or public insurance, such as Medicare, Medicaid, and health maintenance organization plans; and non-insured patients. The company was formerly known as Apollo Medical Holdings, Inc. and changed its name to Astrana Health, Inc. in February 2024. Astrana Health, Inc. was incorporated in 1985 and is headquartered in Alhambra, California.

About Greenpro Capital

(Get Free Report)

Greenpro Capital Corp. provides financial consulting and corporate advisory services to small and medium-size businesses primarily in Hong Kong, Malaysia, and China. It operates in two segments, Service Business and Real Estate Business. The company offers business consulting and corporate advisory services, including cross-border listing advisory, tax planning, bookkeeping, advisory and transaction, record management, and accounting outsourcing services; and venture capital related education and support services. It is also involved in the acquisition and rental of real estate properties held for investment and sale; and provision of company formation advisory, company secretarial, and financial services. In addition, the company provides corporate advisory services, such as company review, bank loan advisory, and bank products analysis, as well as loan and credit, and insurance brokerage services; and wealth planning, administration, charity, tax and legal, trusteeship and risk management, investment planning and management, and business support services, as well as asset protection and management, consolidation, and performance monitoring services. The company was formerly known as Greenpro, Inc. and changed its name to Greenpro Capital Corp. in May 2015. Greenpro Capital Corp. was incorporated in 2013 and is headquartered in Kuala Lumpur, Malaysia.

Receive News & Ratings for Astrana Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Astrana Health and related companies with MarketBeat.com's FREE daily email newsletter.